Search
    ×

    Press releases

    Advanced Search
    • Feb 11, 2014
      BD and USAID Collaborate to Support National TB Program Capacity Building and Development Goals

      SURABAYA, February 11, 2014 – In an ongoing effort to prevent and control infectious disease outbreaks globally, the U.S. Agency for International Development (USAID) and Becton, Dickinson and...

    • Feb 7, 2014

      FRANKLIN LAKES, N.J., February 7, 2014 – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global technology company, today announced the appointment of Amit Bhalla as Vice President,...

    • Feb 7, 2014

      BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following investor healthcare conferences in February 2014:...

    • Feb 4, 2014
      -- Raises the bottom end of full fiscal year 2014 revenue and earnings ranges for guidance.

      BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.0 billion for the first fiscal quarter ended December 31, 2013,...

    • Feb 3, 2014
      Second quarter revenue increased to $922 million, driven by continued strength in the company's Procedural Solutions segment

      SAN DIEGO, CA, Feb. 3, 2014 /PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its second quarter of fiscal 2014,...

    • Jan 29, 2014
      CareFusion, Terumo Sign Distribution Agreement For IV Catheters

      SAN DIEGO, CA, Jan. 29, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, and Terumo Corporation, the largest medical technology company in Japan, today...

    • Jan 28, 2014

      The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 54.5 cents per common share payable on March 31, 2014 to holders of record on March...

    • Jan 14, 2014

      BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 28,...

    • Jan 13, 2014
      BD MAX(TM) MRSA XT Assay with eXTended Detection Technology Receives FDA Clearance

      BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has received FDA clearance to market the BD MAX(TM) MRSA XT

    • Jan 10, 2014

      SAN DIEGO, CA, Jan. 9, 2014 /PRNewswire/ – CareFusion Corporation (NYSE: CFN) today announced plans to release second quarter fiscal 2014 results on Monday, Feb. 3, following the close of...